Wolverine Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87.5K | Hold |
88,906
| – | – | ﹤0.01% | 749 |
|
|
2025
Q1 | $128K | Buy |
88,906
+1,522
| +2% | +$2.19K | ﹤0.01% | 718 |
|
|
2024
Q4 | $192K | Hold |
87,384
| – | – | ﹤0.01% | 678 |
|
|
2024
Q3 | $144K | Hold |
87,384
| – | – | ﹤0.01% | 688 |
|
|
2024
Q2 | $194K | Hold |
87,384
| – | – | ﹤0.01% | 650 |
|
|
2024
Q1 | $234K | Hold |
87,384
| – | – | ﹤0.01% | 600 |
|
|
2023
Q4 | $261K | Hold |
87,384
| – | – | ﹤0.01% | 659 |
|
|
2023
Q3 | $85.6K | Hold |
87,384
| – | – | ﹤0.01% | 811 |
|
|
2023
Q2 | $121K | Hold |
87,384
| – | – | ﹤0.01% | 735 |
|
|
2023
Q1 | $139K | Hold |
87,384
| – | – | ﹤0.01% | 782 |
|
|
2022
Q4 | $544K | Sell |
87,384
-57,861
| -40% | -$360K | 0.01% | 658 |
|
|
2022
Q3 | $973K | Sell |
145,245
-2,624
| -2% | -$17.6K | 0.01% | 593 |
|
|
2022
Q2 | $940K | Sell |
147,869
-1,732
| -1% | -$11K | 0.01% | 625 |
|
|
2022
Q1 | $694K | Buy |
149,601
+5,969
| +4% | +$27.7K | 0.01% | 714 |
|
|
2021
Q4 | $718K | Buy |
143,632
+28,432
| +25% | +$142K | 0.01% | 696 |
|
|
2021
Q3 | $1.39M | Buy |
115,200
+40,200
| +54% | +$484K | 0.01% | 439 |
|
|
2021
Q2 | $1.59M | Buy |
+75,000
| New | +$1.59M | 0.01% | 366 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1807 |
|